MX2018011330A - Formas polimorficas de un oxiesterol y metodos para realizarlas. - Google Patents

Formas polimorficas de un oxiesterol y metodos para realizarlas.

Info

Publication number
MX2018011330A
MX2018011330A MX2018011330A MX2018011330A MX2018011330A MX 2018011330 A MX2018011330 A MX 2018011330A MX 2018011330 A MX2018011330 A MX 2018011330A MX 2018011330 A MX2018011330 A MX 2018011330A MX 2018011330 A MX2018011330 A MX 2018011330A
Authority
MX
Mexico
Prior art keywords
polymorph form
polymorph
oxy133
methods
oxysterol
Prior art date
Application number
MX2018011330A
Other languages
English (en)
Inventor
E Harrington Roger
C Jacobs Jerbrena
Original Assignee
Warsaw Orthopedic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warsaw Orthopedic Inc filed Critical Warsaw Orthopedic Inc
Publication of MX2018011330A publication Critical patent/MX2018011330A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proporcionan las composiciones y los métodos para la preparación de OXY133 polimorfo. Estas composiciones y métodos incluyen someter una suspensión de OXY133 a condiciones suficientes para convertir OXY133 en OXY133 polimorfo Forma A, polimorfo Forma B, polimorfo Forma C, polimorfo Forma D, polimorfo Forma E, polimorfo Forma F, polimorfo Forma G, polimorfo Forma H, polimorfo Forma I, o una mezcla de estas. También se proporciona un polimorfo de OXY133, y el polimorfo puede ser polimorfo Forma A, polimorfo Forma B, polimorfo Forma C, polimorfo Forma D, polimorfo Forma E, polimorfo Forma F, polimorfo Forma G, polimorfo Forma H, polimorfo Forma I, o una mezcla de estos. También se proporcionan las composiciones farmacéuticas que incluyen OXY133 polimorfos.
MX2018011330A 2016-03-28 2017-03-27 Formas polimorficas de un oxiesterol y metodos para realizarlas. MX2018011330A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/082,695 US20170275330A1 (en) 2016-03-28 2016-03-28 Polymorphic forms of an oxysterol and methods of making them
PCT/US2017/024302 WO2017172615A1 (en) 2016-03-28 2017-03-27 Polymorphic forms of an oxysterol and methods of making them

Publications (1)

Publication Number Publication Date
MX2018011330A true MX2018011330A (es) 2019-03-28

Family

ID=59897793

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011330A MX2018011330A (es) 2016-03-28 2017-03-27 Formas polimorficas de un oxiesterol y metodos para realizarlas.

Country Status (8)

Country Link
US (1) US20170275330A1 (es)
EP (1) EP3436039A4 (es)
JP (2) JP2019511510A (es)
CN (1) CN108884125A (es)
AU (1) AU2017241541B2 (es)
BR (1) BR112018069662A2 (es)
MX (1) MX2018011330A (es)
WO (1) WO2017172615A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9637514B1 (en) * 2015-10-26 2017-05-02 MAX BioPharma, Inc. Oxysterols and hedgehog signaling
US10688222B2 (en) 2016-11-21 2020-06-23 Warsaw Orthopedic, Inc. Lyophilized moldable implants containing an oxysterol
US11384114B2 (en) 2016-12-09 2022-07-12 Warsaw Orthopedic, Inc. Polymorphic forms of an oxysterol and methods of making them
US10434106B2 (en) * 2017-05-19 2019-10-08 Warsaw Orthopedic, Inc. Oxysterol-statin compounds for bone growth

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048610A1 (en) * 2000-01-07 2002-04-25 Cima Michael J. High-throughput formation, identification, and analysis of diverse solid-forms
WO2012024584A2 (en) * 2010-08-20 2012-02-23 Fate Therapeutics, Inc. Oxysterol compounds
EP2847206A4 (en) * 2012-05-07 2016-01-20 Univ California OXYSTEROL ANALOGUE OXY133 FOR INDUCTION OF OSTEOGENESIS AND HEDGEHOG SIGNALING AND ADIPOGENESIS INHIBITION
EP2847205A4 (en) * 2012-05-07 2016-01-20 Univ California OXYSTEEL'S NEW ANALOGUE, OXY149, FOR OSTEOINDUCTION, HEDGEHOG SIGNALING AND INHIBITION OF ADIPOGENESIS
US9512170B2 (en) * 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
CA2945404A1 (en) * 2014-05-02 2015-11-05 The Regents Of The University Of California Bone-selective osteogenic oxysterol bisphosphonate analogs
CN107427526B (zh) * 2014-12-09 2021-08-03 华沙整形外科股份有限公司 涉及甾醇的化合物和方法
US10632230B2 (en) * 2015-07-10 2020-04-28 Warsaw Orthopedic, Inc. Implants having a high drug load of an oxysterol and methods of use
US11384114B2 (en) * 2016-12-09 2022-07-12 Warsaw Orthopedic, Inc. Polymorphic forms of an oxysterol and methods of making them

Also Published As

Publication number Publication date
JP2019511510A (ja) 2019-04-25
CN108884125A (zh) 2018-11-23
EP3436039A4 (en) 2019-11-27
BR112018069662A2 (pt) 2019-02-05
AU2017241541B2 (en) 2021-12-09
JP2021169501A (ja) 2021-10-28
WO2017172615A1 (en) 2017-10-05
EP3436039A1 (en) 2019-02-06
US20170275330A1 (en) 2017-09-28
AU2017241541A1 (en) 2018-09-20

Similar Documents

Publication Publication Date Title
ZA201908409B (en) Method for the preparation of synthesis gas
ZA201908183B (en) Method for the preparation of synthesis gas
IL271941A (en) A method for making synthesis gas
MX2017006563A (es) Esteroides de 6-alquil-7-hidroxi-4-en-3-ona como intermedios para la produccion de moduladores esteroides del receptor x farnesoide (fxr).
MX2018011330A (es) Formas polimorficas de un oxiesterol y metodos para realizarlas.
MX2017006564A (es) Esteroides 5.beta.-6-alquil-7-hidroxi-3-ona como intermedios para la produccion de moduladores esteroideos del receptor x farnesoide (fxr).
MX2017006565A (es) Esteroides 6.alfa.-alquil-3,7-diona como intermedios para la produccion de moduladores esteroides del receptor x farnesoide (fxr).
MX2022009886A (es) Reaccion de prins y compuestos utiles en la sintesis de macrolidos de halicondrina y analogos de los mismos.
WO2015121379A3 (en) Process for producing vanillin
EP3333175A3 (en) Polymorphic forms of an oxysterol and methods of making them
PL3717457T4 (pl) Sposób wytwarzania enzalutamidu z wykorzystaniem nowych związków pośrednich
WO2016024286A3 (en) An improved process for synthesis of lenalidomide
BR112016025024A2 (pt) ?processo para preparar compostos ceto, e, uso de farnesil acetona?
IN2015CH01182A (es)
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
ZA202101837B (en) Method for the preparation of synthesis gas
PL3737678T3 (pl) Sposób wytwarzania dipodstawionych związków diaryloksybenzoheterodiazolowych
MX2019014861A (es) Compuestos de quinolinilciclohexilpropanamida sustituidos y metodos mejorados para su preparacion.
WO2016084100A3 (en) Novel and efficient method for large scale synthesis of romidepsin
GB201814291D0 (en) Process for the production of gallium radionculides
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
ZA201907517B (en) Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives
IN2015CH02092A (es)
GB2573115B (en) Process for the preparation of oxamyl
RS63067B1 (sr) Proces pripreme piperazinskog prstena za sintezu derivata pirazinokarbazola